MLICM
BCLI

Metropolitan Life Insurance Company (MetLife)’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-606
Closed -$154K – 2541
2020
Q3 		$154K Hold
606
– – ﹤0.01% 1943
2020
Q2 		$102K Buy
+606
New +$102K ﹤0.01% 2249